These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 187432

  • 1. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D, Da Prada M, Pletscher A.
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE, Nagel M, Schümann HJ.
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [Abstract] [Full Text] [Related]

  • 3. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain.
    Wise CD, Belluzzi JD, Stein L.
    Pharmacol Biochem Behav; 1977 Dec; 7(6):549-53. PubMed ID: 201940
    [Abstract] [Full Text] [Related]

  • 4. Discrimination of monoamine uptake by membranes of adrenal chromaffin granules.
    Da Prada M, Obrist R, Pletscher A.
    Br J Pharmacol; 1975 Feb; 53(2):257-65. PubMed ID: 1148486
    [Abstract] [Full Text] [Related]

  • 5. Effects of dopamine-beta-hydroxylase inhibitors FLA-57 and FLA-63 on ethanol metabolism and aldehyde dehydrogenase activity in rats.
    Tottmar O, Hellström E, Holmberg K, Lindros KO.
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):198-202. PubMed ID: 7136724
    [Abstract] [Full Text] [Related]

  • 6. Molecular organization of the chromaffin vesicles of the adrenal medulla.
    Kirshner N.
    Adv Cytopharmacol; 1974 Sep; 2():265-72. PubMed ID: 4280242
    [No Abstract] [Full Text] [Related]

  • 7. Immunoelectron microscopic localization of dopamine beta-hydroxylase and chromogranin A in adrenomedullary chromaffin cells.
    Matsumoto S, Tanaka K, Yamamoto A, Nakada H, Uchida M, Tashiro Y.
    Cell Struct Funct; 1987 Oct; 12(5):483-96. PubMed ID: 3677182
    [Abstract] [Full Text] [Related]

  • 8. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z, Levitan DE, Lindros KO.
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [Abstract] [Full Text] [Related]

  • 9. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.
    Bourdélat-Parks BN, Anderson GM, Donaldson ZR, Weiss JM, Bonsall RW, Emery MS, Liles LC, Weinshenker D.
    Psychopharmacology (Berl); 2005 Nov; 183(1):72-80. PubMed ID: 16163519
    [Abstract] [Full Text] [Related]

  • 10. The anticonvulsant action of methazolamide in mice: antagonism by various inhibitors of dopamine beta-hydroxylase.
    Lotti VJ, Torchiana ML, Stone CA.
    Eur J Pharmacol; 1977 Aug 15; 44(4):387-90. PubMed ID: 19268
    [Abstract] [Full Text] [Related]

  • 11. Membranes of the adrenal medulla: a comparison between the membranes of the Golgi apparatus and chromaffin granules.
    Trifaró JM, Duerr AC, Pinto JE.
    Mol Pharmacol; 1976 Jul 15; 12(4):536-45. PubMed ID: 134254
    [No Abstract] [Full Text] [Related]

  • 12. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A.
    Pol J Pharmacol Pharm; 1975 Jul 15; 27(2):153-9. PubMed ID: 239395
    [Abstract] [Full Text] [Related]

  • 13. Effect of neuroleptics and other drugs on monoamine uptake by membranes of adrenal chromaffin granules.
    Pletscher A.
    Br J Pharmacol; 1977 Mar 15; 59(3):419-24. PubMed ID: 584682
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.
    Aunis D, Miras-Portugal MT, Mandel P.
    Biochem Pharmacol; 1973 Oct 15; 22(20):2581-9. PubMed ID: 4763594
    [No Abstract] [Full Text] [Related]

  • 15. The effects of some dopamine-beta-hydroxylase inhibitors on the control mechanisms of the estrous cycle in rats.
    Kun I.
    Endocrinologie; 1978 Oct 15; 16(4):263-8. PubMed ID: 569899
    [Abstract] [Full Text] [Related]

  • 16. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR, Beninger RJ, Eikelboom R.
    Pharmacol Biochem Behav; 1985 Apr 15; 22(4):535-40. PubMed ID: 3991764
    [Abstract] [Full Text] [Related]

  • 17. ATPase and phosphatidylinositol kinase activities of adrenal chromaffin vesicles.
    Muller TW, Kirshner N.
    J Neurochem; 1975 Jun 15; 24(6):1155-61. PubMed ID: 165261
    [No Abstract] [Full Text] [Related]

  • 18. Stimulatory effect of ascorbic acid on norepinephrine biosynthesis in digitonin-permeabilized adrenal medullary chromaffin cells.
    Morita K, Levine M, Pollard HB.
    J Neurochem; 1986 Mar 15; 46(3):939-45. PubMed ID: 3485180
    [Abstract] [Full Text] [Related]

  • 19. Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat.
    Battista AF, Flamm ES, Goldstein M, Freedman LS.
    J Neurosurg; 1976 Feb 15; 44(2):168-72. PubMed ID: 1245859
    [Abstract] [Full Text] [Related]

  • 20. Artifactual subcellular distribution of dopamine beta-hydroxylase. Effects of dilution and non-specific protein on the dopamine beta-hydroxylase activity of membranes of adrenomedullary and sympathetic nerve vesicles.
    Lagercrantz H, Stjärne L, Flatmark T, Helle KB.
    Biochem Pharmacol; 1973 Dec 01; 22(23):3005-11. PubMed ID: 4357482
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.